You are not logged in
Login
Create Account
Meetings
Help
Contact Us
Visit our Twitter
Visit our LinkedIn
GU CONNECT Experts Knowledge Share
Post-Meeting Survey
If you wish to view the details for the meeting, then please click the button.
Back to the Meeting Details
1. At what stage would you most likely perform genetic HRR testing for a patient with advanced prostate cancer?
*
At the time of diagnosis of mHSPC
Prior to treatment initiation for mCRPC
At disease progression of mCRPC
I would not routinely recommend testing for HRR mutations
2. What would be your treatment of choice for a mCRPC patient with a BRCA2 mutation, whose disease has progressed after first line treatment with ADT and abiraterone?
*
Docetaxel
Lu-PSMA
Olaparib
Rucaparib
Other
3. What would be your first-line treatment choice for a mCRPC patient with no HRR mutation and biochemical progression who previously received ADT and docetaxel at mCSPC stage?
*
Abiraterone + PARP inhibitor
Abiraterone
Lu-PSMA
PARP inhibitor
Other
4. What would be your first-line treatment choice for a mCRPC patient with a BRCA2 mutation and biochemical progression who previously received ADT and docetaxel at mCSPC stage?
*
Abiraterone + PARP inhibitor
Abiraterone
Lu-PSMA
PARP inhibitor
Other
5. On a scale of 1 to 5, how valuable (with 5 as extremely valuable) did you find this Experts Knowledge Share on Incorporating PARP inhibitors into prostate cancer clinical practice?
*
1
2
3
4
5
6. On a scale of 1 to 5, how strongly do you agree that your knowledge of Incorporating PARP inhibitors into prostate cancer clinical practice has improved as a result of participating in this programme (with 5 as very strongly agree)?
*
1
2
3
4
5
7. Are you planning to change your clinical practice based upon your participation in this Experts Knowledge Share?
*
Yes
Possibly
No, the content confirms my current practice
No, I am unable to change my current practice
8. On average how many patients with prostate cancer do you see each month?
*
I do not see people with advanced prostate cancer
1 - 5
6 - 10
10 - 20
> 20
9. On a scale of 1-5 (with 5 as very balanced and unbiased), to what extent do you feel this Experts Knowledge Share was balanced and unbiased?
*
1
2
3
4
5
10. Do you have any other comments or feedback?
Email Address
*
Send Feedback
COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.
Bodenackerstrasse 17
4103 Bottmingen
Switzerland
Products
Webinars
Meetings
On Demand
SUPPORT
HELP
CONTACT US
Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved
Cookies
Privacy Policy
map-marker
sign-in
user-plus
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept
View Cookie Policy
